Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

NCT06426056 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

RADIATION: radiotherapy
DRUG: Nab paclitaxel
DRUG: Cisplatin

Sponsor

Peking University Third Hospital

Collaborators

[object Object]
[object Object]
[object Object]